Status:
TERMINATED
A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment
Lead Sponsor:
Rabin Medical Center
Conditions:
Child Development Disorders, Pervasive
Eligibility:
All Genders
2-5 years
Phase:
NA
Brief Summary
The current study aims at comparing outcomes achieved using the Mifne approach of treating autistic children with results obtained when routine standard treatment is used. A prospective comparative st...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All children between the ages of 2-5 years who meet diagnostic criteria for Autism or Pervasive Developmental Disorder by DSM IV criteria who are referred for treatment at Mifne for the treatment group.
- The control group will consist of children meeting the same criteria who are referred to Schneider Children's Medical Center of Israel (SCMCI). Matching will be for age, sex, ethnicity, socioeconomic status, IQ, language development and diagnosis.
- Exclusion criteria:
- All referred children who do not meet criteria for Autism or PDD or do not understand Hebrew.
Exclusion
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00445471
Start Date
April 1 2007
End Date
December 1 2012
Last Update
December 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schneider Children's Medical Center of Israel, Departemnt of Psychological Medicine
Petah Tikva, Israel